Palvella Therapeutics Share Price (NASDAQ: PVLA)
$53.9
▲
2.6
(5.07%)
Last updated on
Check the interactive Palvella Therapeutics Stock chart to analyse performance
Palvella Therapeutics stock performance
as on August 30, 2025 at 1:29 am IST
- Today's Low:$50.19Today's High:$53.90
6.88%
Downside
Day's Volatility :6.88%
Upside
0.0%
- 52 Weeks Low:$11.1752 Weeks High:$57.19
79.28%
Downside
52 Weeks Volatility :80.47%
Upside
5.75%
Palvella Therapeutics Stock Returns
Palvella Therapeutics, Inc. Key Stats
Check Palvella Therapeutics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.
Stock Returns calculator for Palvella Therapeutics Stock including INR - Dollar returns
The Palvella Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Palvella Therapeutics investment value today
Current value as on today
₹3,14,167
Returns
₹2,14,167
(+214.17%)
Returns from Palvella Therapeutics Stock
₹2,08,883 (+208.88%)
Dollar Returns*
₹5,284 (+5.28%)
Indian investors sentiment towards Palvella Therapeutics Stock
Analyst Recommendation on Palvella Therapeutics Stock
Palvella Therapeutics Share Price Target
What analysts predicted
Downside of 30.74%
Target:
$37.33
Current:
$53.90
Palvella Therapeutics share price target is $37.33, a slight Downside of 30.74% compared to current price of $53.90 as per analysts' prediction.
Palvella Therapeutics Stock Insights
Price Movement
In the last 1 month, PVLA stock has moved up by 43.9%Decreasing Revenue
Revenue is down for the last 4 quarters, 20.05M → 53.0K (in $), with an average decrease of 64.0% per quarterDecreasing Net Profit
Netprofit is down for the last 3 quarters, -2.88M → -9.47M (in $), with an average decrease of 99.6% per quarterPVLA vs ALNY (3 yr)
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 112.6% return, outperforming this stock by 166.8%
Palvella Therapeutics Technicals Summary
Sell
Neutral
Buy
Palvella Therapeutics is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
Palvella Therapeutics, Inc. Vs Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
| 47.41% | 175.6% | 208.77% | -52.57% | -75.86% |
 | 6.48% | -15.2% | -50.31% | -3.3% | -2.01% |
| 1.77% | 24.81% | 62.78% | 79.11% | 29.69% |
 | -14.45% | -19.13% | -17.84% | 34.68% | 41.87% |
 | 13.79% | 83.28% | 75.87% | 111.28% | 242.25% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
| 9.92 | 9.92 | NA | -3.27 | 0.0 | 0.0 | NA | -15.28 |
| 14.6 | 14.6 | 1.2 | 39.42 | 0.15 | 0.07 | 0.0 | 287.55 |
| NA | NA | NA | 2.73 | -0.05 | -0.01 | NA | 34.32 |
| 27.86 | 27.86 | 0.58 | 18.06 | 0.23 | 0.13 | NA | 67.02 |
| NA | NA | -0.49 | 3.92 | -2.58 | -0.03 | NA | 1.91 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
| NA | $219.4M | -75.86% | 9.92 | 0.0% |
| Buy | $61.4B | -2.01% | 14.6 | 31.37% |
| NA | $36.5B | 29.69% | NA | -3.89% |
| Buy | $100.5B | 41.87% | 27.86 | 31.86% |
| Buy | $59.5B | 242.25% | NA | -12.96% |
About Palvella Therapeutics, Inc.
Key Management of Palvella Therapeutics, Inc.
Important FAQs about investing in PVLA Stock from India :
What is Palvella Therapeutics share price today?
Palvella Therapeutics share price today is $53.90 as on at the close of the market. Palvella Therapeutics share today touched a day high of $53.90 and a low of $50.19.
What is the 52 week high and 52 week low for Palvella Therapeutics share?
Palvella Therapeutics share touched a 52 week high of $57.19 and a 52 week low of $11.17. Palvella Therapeutics stock price today i.e. is closed at $53.90, lower by 5.75% versus the 52 week high.
How to invest in Palvella Therapeutics Stock (PVLA) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Palvella Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Palvella Therapeutics Shares that will get you 0.0278 shares as per Palvella Therapeutics share price of $53.90 per share as on August 30, 2025 at 1:29 am IST.
What is the minimum amount required to buy Palvella Therapeutics Stock (PVLA) from India?
Indian investors can start investing in Palvella Therapeutics (PVLA) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Palvella Therapeutics stock (as per the Rupee-Dollar exchange rate as on August 31, 2025).
Based on Palvella Therapeutics share’s latest price of $53.90 as on August 30, 2025 at 1:29 am IST, you will get 0.1855 shares of Palvella Therapeutics. Learn more about
fractional shares .
What are the returns that Palvella Therapeutics has given to Indian investors in the last 5 years?
Palvella Therapeutics stock has given -75.86% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?
Discover More
- Webs Defined Volatility Xle
$24.99
-0.04%
- United States 12 Month Natur
$7.81
+1.83%
- F/m U S T Inl-p S (tips) Etf
$50.14
+0.06%
- Pgim Jennison Focused Growth Etf
$105.89
-1.37%
Hitek Global Inc$1.49
+1.36%
Vaneck Vectors Preferred Secs Ex Finls Etf$17.68
-0.73%
Marker Therapeutics Inc$0.93
+3.33%
- Cambria Value And Momentum Etf
$32.55
+0.25%